Stock Ticker

  • Loading stock data...

TherapeuticsMD Enters $8.5 Million Private Placement Agreement (TXMD)

Specialty pharmaceutical company TherapeuticsMD (OTC: TXMD) has just made a positive announcement for shareholders and investors by revealing information about a Securities Purchase Agreement that it has signed with accredited investors. As per the terms of the agreement, TherapeuticsMD has agreed to enter 3,953,489 of its common stock shares in a private placement at a […]

Save the World Air Announces Results of Shareholder Meeting (ZERO)

The annual shareholder’s meeting for Save the World Air (OTC: ZERO) has successfully taken place on September 21, 2012. The company has just released the minutes of the meeting as well as the results of the shareholder’s decisions taken on the day. The company is fast becoming an industry leader in the field of developing applicable solutions […]

Cellceutix Announces Commencement of Clinical Trials for Anti-Cancer Drug Kevetrin (CTIX)

Cellceutix (OTC: CTIX) has just made a positive announcement for its shareholders who will be happy to know that the company is all set to start clinical trials for its novel anti-cancer drug Kevetrin. The announcement was made earlier in the day, and the clinical trials will be undertaken at the Harvard Cancer Center’s Dana […]

Fortunes Fade for Pristine Solutions (PRTN)

Everything seems to be going downhill for Pristine Solutions (OTC: PRTN) after it was picked as one of the AwesomePennyStocks (APS) that had a bright future. Every investor with a stake in the company would have been holding his or her breath while waiting for Pristine Solutions to hit several dollars per share just like […]

InVivo Therapeutics Promotes Brian Hess as CSO (NVIV)

InVivo Therapeutics (OTC: NVIV) has just announced that its director of product development, Brian Hess, will be taking over as the Chief Science Officer for the company. Hess joined InVivo just months before and will be taking over from Edward Wirth M.D., Ph.D. About InVivo InVivo Therapeutics is a developer of new technology pertaining to […]

Traders in Pristine Solutions Keep Their Emotions in Check (PRTN)

How hot or cold can a stock get from a research report created by a non-registered, small cap equity research firm? Traders probably pondered that question a bit during the trading session today. This morning, 2nd Opinion Stock Research out of New Orleans, Louisiana, initiated coverage on Pristine Solutions (OTC: PRTN). Judging from the action in the […]

Pristine Solutions Prepares for FDA Approval of Tropine 3 Transdermal Patch (PRTN)

Shares of Pristine Solutions (OTC: PRTN) have fallen by a small margin of about 1.1%, or $0.0041 per share, to reach $0.3849 as of September 12, 2012. One of the most actively traded penny stock companies, Pristine Solutions is the flagship company that has a wholly owned subsidiary company, Eaton Scientific Systems, under its wings. The […]

Protocol Completion For Tropine 3 Clinical Trial Ensures Rally In Pristine Solutions (PRTN)

Following the news of an agreement with Rox San Pharmacy and completion of Protocol for the Clinical Trial for Tropine 3, the shares of Pristine Solutions (OTC: PRTN) continued the upward journey with a 76% gain from an intra-day low of $0.17 on September 4, 2012. Pristine Solutions came into the lime light nearly two […]

Chimera Energy and Pristine Solutions Remain Bankable as Starbucks Tries to Kick Up the Caffeine Kick (CHMR) (PRTN)

Starbucks (NASDAQ: SBUX) accepts the help from LivingSocial to increase popularity while market reports suggest that penny stock companies such as Chimera Energy (OTC: CHMR) and Pristine Solutions (OTC: PRTN) are named the most bankable stocks to trade in the OTC market based on their financial standing. The markets are continually shifting. There are plenty of […]

A Pristine Day for Pristine Solutions while Nokia Slides (PRTN)

Despite flooding the market with Windows-powered smartphones, troubles for Nokia (NYSE: NOK) are far from over. On the other hand, Pristine Solutions (OTC: PRTN) is having a field day in the OTC market buoyed by its recent acquisition of Eaton Scientific Systems. Market forces are applying increasing pressure to behemoths like Apple, Microsoft and Google […]

Sign Up To Get Our Latest Stocks Alerts